Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Neumora Therapeutics Inc shares valued at $239,319 were sold by Fust Matthew K on Oct 18 ’24. At $17.03 per share, Fust Matthew K sold 14,049 shares. The insider’s holdings dropped to 20,100 shares worth approximately $34170.0 following the completion of this transaction.
Also, Fust Matthew K sold 7,739 shares, netting a total of over 131,643 in proceeds. Following the sale of shares at $17.01 each, the insider now holds 20,100 shares.
Before that, Fust Matthew K had added 14,049 shares to its account. In a trade valued at $239,319, the Director bought Neumora Therapeutics Inc shares for $17.03 each.
As published in a research note from RBC Capital Mkts on January 02, 2025, Neumora Therapeutics Inc [NMRA] has been rated down from an Outperform to a Sector perform and the price target has been revised to $4 from $29. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in early November. As of October 01, 2024, H.C. Wainwright has initiated its “Buy” rating for NMRA. Earlier on July 22, 2024, Needham initiated its rating. Their recommendation was “a Buy” for NMRA stock.
Analyzing NMRA Stock Performance
During the last five days, there has been a drop of approximately -12.37%. Over the course of the year, Neumora Therapeutics Inc shares have dropped approximately -83.96%. Shares of the company reached a 52-week high of $2.8600 on 01/07/25 and a 52-week low of $1.6000 on 02/12/25. A 50-day SMA is recorded $5.7691, while a 200-day SMA reached $9.9497. Nevertheless, trading volume fell to 2.13 million shares from 1.67 million shares the previous day.
Support And Resistance Levels for Neumora Therapeutics Inc (NMRA)
According to the 24-hour chart, there is a support level at 1.6233, which, if violated, would cause prices to drop to 1.5467. In the upper region, resistance lies at 1.7533. The next price resistance is at 1.8067. RSI (Relative Strength Index) is 21.44 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1833, which suggests the price will decrease in the coming days. Percent R is at 82.76%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
